Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Crk I Inhibitors

Crk I inhibitors represent a specialized class of compounds targeting the Crk I protein, an adapter protein involved in various signaling pathways that regulate cellular functions such as proliferation, migration, and differentiation. Crk I is a member of the Crk family of proteins, which act as intermediaries that link activated receptors to downstream signaling cascades. By binding to specific phosphorylated tyrosine residues on other proteins, Crk I facilitates the assembly of signaling complexes that promote cellular responses to external stimuli. The modulation of Crk I activity through inhibitors can significantly influence the behavior of cells, making it an important focus for researchers studying cellular signaling mechanisms.

The development of Crk I inhibitors typically involves the identification of small molecules or peptides that can effectively disrupt the interaction between Crk I and its target proteins. These inhibitors are often designed using structure-based approaches, allowing researchers to visualize and predict how these compounds will interact with the Crk I protein. The efficacy of these inhibitors is assessed through a variety of biochemical assays that measure their ability to inhibit Crk I function and downstream signaling events. By exploring the molecular interactions and conformational changes induced by these inhibitors, scientists aim to gain deeper insights into the role of Crk I in cellular processes. As a result, Crk I inhibitors are valuable tools for dissecting complex signaling networks and understanding the functional implications of Crk I in different biological contexts.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib prevents the degradation of IκB, an inhibitor of NF-κB, which may result in decreased NF-κB-mediated transcription of the CRK gene, thereby reducing Crk I protein levels.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

Nutlin-3 disrupts the interaction between p53 and MDM2, potentially leading to enhanced p53-mediated transcriptional repression of the CRK gene and subsequent downregulation of Crk I protein synthesis.